Bausch Health Companies | VRX - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Amgen USD 13.99B 1.95B 2026-06
ANI Pharmaceuticals USD 360.21M 49.04M 2026-06
Aurora Cannabis CAD 64.69M 8.33M 2026-03
Bausch Health Companies USD 1.83B 526M 2026-06
Biogen USD 1.28B 2.1B 2026-06
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Canopy Growth CAD 364.68M 6.64M 2026-03
Corcept Therapeutics USD 111.04M 2.3M 2026-06
Danaher USD 4.35B 1.35B 2026-06
Drreddys Laboratories INR 15.37B 3.29B 2026-03
Eli Lilly USD 8.95B 3.67B 2026-06
Gilead Sciences USD 7.63B 64M 2026-03
Nektar Therapeutics USD 149.58M 134.46M 2026-03
Novo Nordisk A/S DKK 18.44B 5.78B 2025-06
Pacira USD 205.88M 61.57M 2026-06
Perrigo USD 357.2M 174.4M 2026-03
Phibro Animal Health USD 54.93M 557K 2026-03
Prestige Brands USD 89.13M 25.26M 2026-06
Supernus Pharmaceuticals USD 179.95M 4.92M 2026-06
Vertex Pharmaceuticals USD 7.85B 605.7M 2026-06
Zoetis USD 1.48B 465M 2026-06